Company Profiles

driven by the PitchBook Platform

Acer Therapeutics

Description

Developer of pharmaceutical therapeutics designed to treat serious rare diseases with critical unmet medical need. The company's pharmaceutical therapeutics offer treatment for serious ultra-rare diseases and severe genetic disorders, enabling healthcare companies to treat vascular ehlers-danlos syndrome and treatments of urea cycle disorders.

2007

Founded

PRIVATE

Status

1-10

Employees

Reverse Merger

Latest Deal Type

$13.4M

Total Amount Raised

2

Investors

Description

Developer of pharmaceutical therapeutics designed to treat serious rare diseases with critical unmet medical need. The company's pharmaceutical therapeutics offer treatment for serious ultra-rare diseases and severe genetic disorders, enabling healthcare companies to treat vascular ehlers-danlos syndrome and treatments of urea cycle disorders.

Website:

www.acertx.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology
Drug Discovery

Primary Office

222 Third Street Suite 2240 Cambridge, MA 02142United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Acer Therapeutics's full profile, request a free trial.

Acer Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Acer Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Acer Therapeutics Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Bukwang PharmaceuticalCorporationMinority000 0000000 0000
TVM Capital Life ScienceVenture CapitalMinority000 0000000 0000
Bukwang Pharmaceutical Corporation
TVM Capital Life Science Venture Capital

Acer Therapeutics Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Christopher SchellingCo-Founder, Chief Executive Officer, President & Board Member
Pamela WilliamsonActing Vice President, Regulatory Affairs
Benjamin DeweesVice President, Regulatory Affairs and Manufacturing
Robert Steiner MDChief Medical Officer
Harry PalminChief Financial Officer
Christopher Schelling Co-Founder, Chief Executive Officer, President & Board Member
Pamela Williamson Acting Vice President, Regulatory Affairs
Benjamin Dewees Vice President, Regulatory Affairs and Manufacturing
Robert Steiner MD Chief Medical Officer
Harry Palmin Chief Financial Officer

Acer Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Christopher SchellingAcer TherapeuticsCo-Founder, Chief Executive Officer, President & Board Member000 0000
Cynthia Lavoie Ph.DTVM Capital Life ScienceGeneral Partner000 0000
Hubert Birner Ph.DSelfBoard Member000 0000
John Dunn JDAcer TherapeuticsBoard Member000 0000
Luc Marengere Ph.DTVM CapitalManaging Partner000 0000
Christopher Schelling Co-Founder, Chief Executive Officer, President & Board Member Acer Therapeutics
Cynthia Lavoie Ph.D General Partner TVM Capital Life Science
Hubert Birner Ph.D Board Member Self
John Dunn JD Board Member Acer Therapeutics
Luc Marengere Ph.D Managing Partner TVM Capital
Request full access to PitchBook